The global market for healthcare nanotechnology
is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%,
according to a new study by Grand View Research, Inc. Increasing susceptibility
of patients towards chronic diseases such as cardiovascular, neurological,
oncology and respiratory diseases coupled with increasing R&D spending
opening new application avenues is expected to drive market growth over the
next six years. Other drivers of this market include increasing government and
private sector R&D aid and new players entering the market to bridge the
gap between supply and demand.
Clinical oncology nanotechnology applications
dominated the overall market in 2013, accounting for 35% of total market
revenue. Higher efficacy of nanomaterials and the ability of engineered
nanoparticles to cross through the blood brain barrier provides platform for
groundbreaking innovations through R&D in the field of cancer therapy and
serves this market as a high impact rendering driver.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology
Further
key findings from the study suggest:
- North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
- Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
- Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
Browse All Reports of
this category @ http://www.grandviewresearch.com/industry/biotechnology
For the purpose of this study, Grand View Research
has segmented the global healthcare nanotechnology market on the basis of
fields of application and region:
Healthcare
Nanotechnology Application Outlook
•
Drug delivery Systems
•
Molecular Diagnostics
•
Clinical Oncology
•
Clinical Neurology
•
Clinical Cardiology
•
Anti-inflammatory and Anti-infective applications
Healthcare
Nanotechnology Regional Outlook
•
North America
• Europe
•
Asia Pacific
•
RoW
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Blog
Site: http://www.divog.org/
No comments:
Post a Comment